XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash $ 7,596,667 $ 4,356
Prepaid expenses and other current assets 235,951 70,670
Deferred offering costs 546,651
Total current assets 7,832,618 621,677
Total assets 7,832,618 621,677
Current liabilities    
Accounts payable 536,838 1,463,059
Accrued interest 179,621
Due to founder 200,000
Accrued expenses 179,871 318,223
Redemption liability 980,233
Short-term portion of related party convertible notes, net 1,392,544
Total current liabilities 716,709 4,533,680
Related party convertible notes, net of short-term portion 772,899
Total liabilities 716,709 5,306,579
Commitments and contingencies (see Note 8)
Stockholders’ equity (deficit)    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2022 and December 31, 2021
Common stock, $0.0001 par value, 250,000,000 shares authorized, 11,604,970 and 6,357,314 shares issued and 11,529,861 and 6,357,314 shares outstanding as of September 30, 2022 and December 31, 2021, respectively 1,160 636
Additional paid-in capital 20,794,890 2,225,712
Accumulated deficit (13,617,994) (6,911,250)
Treasury stock, at cost, 75,109 and 0 shares held in treasury as of September 30, 2022 and December 31, 2021, respectively (62,147)
Total stockholders’ equity (deficit) 7,115,909 (4,684,902)
Total liabilities and stockholders’ equity (deficit) $ 7,832,618 $ 621,677